X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (77) 77
humans (76) 76
female (57) 57
pathology (52) 52
oncology (48) 48
breast cancer (44) 44
breast neoplasms - pathology (40) 40
immunohistochemistry (32) 32
tumors (31) 31
breast neoplasms - genetics (30) 30
cancer (29) 29
analysis (21) 21
mutation (20) 20
breast neoplasms - metabolism (19) 19
expression (19) 19
carcinoma (18) 18
genetic aspects (18) 18
aged (17) 17
gene amplification (17) 17
cell biology (16) 16
cell line, tumor (16) 16
comparative genomic hybridization (16) 16
middle aged (16) 16
gene expression regulation, neoplastic (14) 14
heterogeneity (14) 14
in-situ hybridization (13) 13
prognosis (13) 13
adult (12) 12
article (12) 12
biomarkers, tumor - analysis (12) 12
in situ hybridization, fluorescence (12) 12
amplification (11) 11
estrogen (11) 11
male (11) 11
skin and connective tissue diseases (11) 11
biomarkers, tumor - genetics (10) 10
breast (10) 10
diagnosis (10) 10
gene expression profiling (10) 10
biomarkers, tumor - metabolism (9) 9
gene expression (9) 9
genomics (9) 9
medical prognosis (9) 9
metastasis (9) 9
animals (8) 8
carcinoma - genetics (8) 8
copy number (8) 8
genetic research (8) 8
mice (8) 8
phenotype (8) 8
research (8) 8
breast carcinoma (7) 7
breast neoplasms - drug therapy (7) 7
carcinoma, ductal, breast - pathology (7) 7
dna (7) 7
gene dosage (7) 7
her2 (7) 7
oligonucleotide array sequence analysis (7) 7
progression (7) 7
recommendations (7) 7
tumor proteins (7) 7
carcinoma, papillary - pathology (6) 6
carcinomas (6) 6
cell proliferation (6) 6
chemotherapy (6) 6
disease progression (6) 6
dna mutational analysis (6) 6
formaldehyde (6) 6
hybridization (6) 6
medicine & public health (6) 6
neoplasms (6) 6
proteins (6) 6
receptor, erbb-2 - genetics (6) 6
receptor, erbb-2 - metabolism (6) 6
research article (6) 6
rna (6) 6
survival (6) 6
tissues (6) 6
adenocarcinoma (5) 5
aged, 80 and over (5) 5
breast neoplasms - chemistry (5) 5
breast neoplasms - diagnosis (5) 5
carcinoma in-situ (5) 5
carcinoma, ductal, breast - genetics (5) 5
carcinoma, ductal, breast - metabolism (5) 5
carcinoma, papillary - metabolism (5) 5
cells (5) 5
chromosome aberrations (5) 5
classification (5) 5
deoxyribonucleic acid--dna (5) 5
ductal carcinoma (5) 5
genes (5) 5
genetic predisposition to disease (5) 5
genetics (5) 5
grade (5) 5
high-throughput nucleotide sequencing (5) 5
in situ hybridization (5) 5
microarray (5) 5
microarrays (5) 5
molecular portraits (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of Pathology, ISSN 0022-3417, 02/2017, Volume 241, Issue 3, pp. 405 - 419
Journal Article
New BIOTECHNOLOGY, ISSN 1871-6784, 09/2019, Volume 52, pp. 104 - 109
Journal Article
Histopathology, ISSN 0309-0167, 10/2012, Volume 61, Issue 4, pp. 629 - 643
Di Palma S, Simpson R H W, Marchiò C, Skálová A, Ungari M, Sandison A, Whitaker S, Parry S & Reis‐Filho J S 
(2012) Histopathology 61, 629–643 Salivary duct... 
basal‐like phenotype | molecular subtypes | androgen receptor | basal cytokeratins | HER2 | salivary duct carcinoma | Basal cytokeratins | Molecular subtypes | Salivary ductcarcinoma | Basal-like phenotype | Androgen receptor | PROGNOSTIC FACTORS | INTRADUCTAL GROWTH | PROGESTERONE-RECEPTORS | PAROTID-GLAND | IN-SITU HYBRIDIZATION | PATHOLOGY | TUMORS | basal-like phenotype | NEGATIVE BREAST-CANCER | CELL BIOLOGY | MOLECULAR PORTRAITS | GRADE | EXPRESSION | Immunohistochemistry | Carcinoma in Situ - classification | Carcinoma, Ductal - classification | Oligonucleotide Array Sequence Analysis | Receptor, ErbB-2 - genetics | Carcinoma, Ductal - genetics | Salivary Gland Neoplasms - genetics | Tissue Array Analysis | Carcinoma, Ductal - pathology | Humans | Middle Aged | Transcriptome | Male | Carcinoma in Situ - genetics | In Situ Hybridization | Receptors, Androgen - analysis | Receptors, Androgen - biosynthesis | Aged, 80 and over | Adult | Female | Carcinoma - pathology | Receptor, ErbB-2 - biosynthesis | Biomarkers, Tumor - analysis | Carcinoma in Situ - pathology | Phenotype | Receptors, Androgen - genetics | Carcinoma - genetics | Salivary Ducts - pathology | Aged | Receptor, ErbB-2 - analysis | Salivary Gland Neoplasms - classification | Carcinoma - classification | Salivary Gland Neoplasms - pathology | Androgens | Epidermal growth factor | Analysis | Genetic aspects | Progesterone | Gene expression | Histochemistry | Cancer
Journal Article
The Journal of Pathology, ISSN 0022-3417, 03/2015, Volume 235, Issue 4, pp. 571 - 580
Mutations in genes encoding proteins involved in RNA splicing have been found to occur at relatively high frequencies in several tumour types including... 
breast cancer | spliceostatin A | alternative splicing | drivers | SF3B1 | next‐generation sequencing | Alternative splicing | Breast cancer | Next-generation sequencing | Drivers | Spliceostatin A | DUCTAL CARCINOMAS | MICROPAPILLARY CARCINOMAS | next-generation sequencing | MYELODYSPLASIA | PATHOLOGY | TUMORS | PRE-MESSENGER-RNA | UVEAL MELANOMA | ONCOLOGY | PATHWAY | GENES | CHRONIC LYMPHOCYTIC-LEUKEMIA | SPLICING FACTOR | Carcinoma, Papillary - genetics | Receptors, Estrogen - metabolism | Adenocarcinoma, Mucinous - pathology | Humans | Gene Expression Regulation, Neoplastic | Phosphoproteins - antagonists & inhibitors | Molecular Targeted Therapy | Phosphoproteins - metabolism | Carcinoma, Papillary - metabolism | Breast Neoplasms - metabolism | Dose-Response Relationship, Drug | Ribonucleoprotein, U2 Small Nuclear - metabolism | Transfection | RNA Interference | Ribonucleoprotein, U2 Small Nuclear - genetics | Female | Antineoplastic Agents - pharmacology | Adenocarcinoma, Mucinous - drug therapy | Pyrans - pharmacology | Cell Survival - drug effects | Genetic Predisposition to Disease | Alternative Splicing - genetics | RNA Splicing Factors | Carcinoma, Papillary - drug therapy | Phosphoproteins - genetics | Breast Neoplasms - drug therapy | Carcinoma, Papillary - pathology | Phenotype | Alternative Splicing - drug effects | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Adenocarcinoma, Mucinous - metabolism | Cell Line, Tumor | Ribonucleoprotein, U2 Small Nuclear - antagonists & inhibitors | Adenocarcinoma, Mucinous - genetics | Mutation | Spiro Compounds - pharmacology | RNA | Leukemia | Genomics | Melanoma | Proteins | Analysis | Pancreatic cancer | Genetic research | Genetic aspects | Nucleotide sequencing | Health aspects | DNA sequencing | Original Papers
Journal Article
The Journal of Pathology, ISSN 0022-3417, 10/2015, Volume 237, Issue 2, pp. 166 - 178
Journal Article
Nature Genetics, ISSN 1061-4036, 11/2014, Volume 46, Issue 11, pp. 1166 - 1169
Journal Article
Journal Article
Cancers, ISSN 2072-6694, 04/2019, Volume 11, Issue 4, p. 454
Hotspot codon 132 mutations (R132xIDH1m) are frequent in intrahepatic cholangiocarcinoma (ICC), are druggable by anti-IDH1m agents, and could represent a... 
IDH1 mutation | Liquid biopsy | Biomarker | qPCR | Intrahepatic cholangiocarcinoma | ISOCITRATE DEHYDROGENASE 1 | PATHOGENESIS | ONCOLOGY | biomarker | intrahepatic cholangiocarcinoma | liquid biopsy
Journal Article
Journal Article
The Journal of Pathology, ISSN 0022-3417, 04/2014, Volume 232, Issue 5, pp. 553 - 565
Journal Article